'Compliance, Risk and Cost of Ownership Comparisons for Pharmaceutical Continuous Monitoring," White paper

Quality manager in pharmaceutical-related industries can now obtain a guide to cutting costs of monitoring critical environments while controlling risk factors from Veriteq, a Vaisala company. This is not a news story, but we feel it may be of significant interest to some of our subscribers or to pass on to their more relevant colleagues.

Copies of this no-cost white paper -“Compliance, Risk and Cost of Ownership Comparisons for Pharmaceutical Continuous Monitoring - Wired, Wireless and Standalone Monitoring Instruments” - can be obtained by writing to ken.appel@vaisala.com.

Six different modalities used in pharmaceutical-related industries for continuous monitoring - chart recorders, standalone data loggers, wired LAN networks with UPS backups, wired LAN networks using Power over Ethernet; WiFi; and Wireless Mesh - are systematically explained and compared in terms of lifetime costs of ownership and risks of non-compliance in the context of today’s regulatory environment.